# A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects

> **NCT00968422** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ABT-384
- **DRUG:** Matching placebo to ABT-384

## Key facts

- **NCT ID:** NCT00968422
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-01
- **Final completion:** —
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2010-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968422, "A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00968422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*